Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.
In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational ...
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]The ...
Global pharmaceutical companies Moderna and MSD announced on the 1st (local time) at the American Society of Clinical ...
A pioneering cancer vaccine, developed through a collaboration between the University of Oxford and pharmaceutical giant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results